Position in ZVRA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$244,230
-$355,640 QoQ
Shares Held
26,205
-60.9% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ZVRA ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ZVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $244,230 | 26,205 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $599,870 | 66,950 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $350,499 | 36,856 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $263,003 | 29,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $230,197 | 30,734 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $247,705 | 29,701 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $124,620 | 17,957 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $134,166 | 27,381 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $138,665 | 23,908 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $155,619 | 23,759 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $101,079 | 20,971 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $92,054 | 18,050 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $27,923 | 5,077 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $23,289 | 5,074 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $32,135 | 5,150 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,593 | 6,187 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $45,903 | 9,126 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $170,123 | 19,532 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $366,397 | 39,271 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $73,317 | 5,719 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $30,589 | 3,325 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||